US · Healthcare · Medical Care Facilities
EPS came in at 6.39 against a street estimate of 5.93 — a beat of 7.8%.
Analysts rate Chemed Corp a buy (3 buy, 2 hold, 0 sell out of 5) with an average price target of $617.00.
CONFIDENT Chemed delivered strong growth led by VITAS, while Roto-Rooter improved revenue but faced marketing, fuel and integration margin pressure. Management expects 2026 adjusted EPS at or slightly above the prior range’s high end. Q3 FY26 Florida ended the Medicare Cap year with more than $34 million of cushion; non-Florida cap billing limitation was approximately $3 million below the original projection. Analysts focused on VITAS staffing and growth, Roto-Rooter acquisition economics, marketing costs and the 2026 outlook. Management emphasized hiring stability, long-term acquisition value and expected margin recovery as revenue scales and leads stabilize. 2026-10-28…
Full summary in the app.
| Fund | Stake |
|---|---|
| BlackRock Inc | 11.45% |
| AQR Capital Management LLC | 7.50% |
| Vanguard Portfolio Management, LLC | 6.07% |
| Vanguard Capital Management, LLC | 4.66% |
| Acadian Asset Management LLC | 3.50% |
| State Street Corp | 3.43% |
| Geode Capital Management, LLC | 3.19% |
| JPMorgan Chase & Co | 3.11% |
| Document | Date |
|---|---|
| Quarterly report · Q3 2026 HEADLINE NUMBERS • Third-quarter 2026 service revenues and sales were $690,940 thousand, up from $624,900 thousand in the third quarter of 2025. • N | 2026-10-29 |
| Results announced · Q4 2026 HEADLINE NUMBERS • Third-quarter 2026 revenue increased 10.6% to $690.9 million. • GAAP diluted EPS rose 22.2% to $5.45; adjusted diluted EPS increa | 2026-10-27 |
| Quarterly report · Q2 2026 CHEMED CORPORATION – Q2 2026 10-Q SUMMARY HEADLINE NUMBERS • Six-month revenue: $1,330.8 million (up 5.1% vs. $1,265.7 million in first six months 2 | 2026-07-31 |
| Results announced · Q3 2026 CHEMED CORPORATION Q2 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Consolidated revenue: $673.3 million, up 8.8% year-over-year • GAAP diluted EPS: $5.1 | 2026-07-28 |
| Shareholder vote results · Q2 2026 CHEMED CORPORATION (CHE) - FORM 8-K SUMMARY HEADLINE NUMBERS • Annual stockholder meeting held May 18, 2026 • Board of 9 directors elected with vary | 2026-05-19 |
| Quarterly report · Q1 2026 CHEMED CORPORATION Q1 2026 10-Q SUMMARY HEADLINE NUMBERS • Total revenues (Q1 2026): $657.513 million vs. $646.943 million (Q1 2025), up 1.6% • Net | 2026-04-28 |
| Results announced · Q2 2026 CHEMED CORPORATION Q1 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Consolidated revenue: $657.5 million, up 1.6% year-over-year • GAAP diluted EPS: $4.8 | 2026-04-23 |
| Material agreement · Q2 2026 CHEMED CORPORATION - FORM 8-K SUMMARY HEADLINE NUMBERS • Renewed senior secured credit facilities totaling $450 million • Five-year revolving credit | 2026-04-13 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | $0.70 / share ex-date Aug 17, 2026 · pay Sep 3, 2026 | 2026-08-17 |
| Dividend | $0.60 / share ex-date May 28, 2026 · pay Jun 16, 2026 | 2026-05-28 |
| Dividend | $0.60 / share ex-date Feb 23, 2026 · pay Mar 13, 2026 | 2026-02-23 |
| Dividend | $0.60 / share ex-date Nov 17, 2025 · pay Dec 5, 2025 | 2025-11-17 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Chemed Corp — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-11-07.